ITRM vs V · rev $390.0K vs P/E 33, rev $40.00B
Iterum Therapeutics PLC (ITRM) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
ITRM currently screens at market cap $38.6M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the ITRM and V stock pages for the full models.
Not investment advice.